The Added Value of (18)F-FDG PET/CT Compared with (68)Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer. Chen R, Wang Y, Zhu Y, Shi Y, et al. J Nucl Med 2022;63:69-75.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen R, Wang Y, Zhu Y, Shi Y, et al. The Added Value of (18)F-FDG PET/CT Compared with (68)Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer. J Nucl Med 2022;63:69-75.
PMID: 34980667